Current practice for clozapine-induced leukopenia in Japanese psychiatric hospitals: A nationwide survey

Prevention of suicide by clozapine in mental disorders: systematic review

(2023) Vasilios G. Masdrakis et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Improving clozapine utilization will require continued advocacy, drug sponsor interest, and FDA support to address REMS issues

(2023) Jonathan G Leung et al.   Expert Review of Clinical Pharmacology

Distinctive pattern of neutrophil count change in clozapine-associated, life-threatening agranulocytosis

(2022) David Taylor et al.   npj Schizophrenia

Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study

(2022) Shinichiro Ochi et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Clozapine Is Better Tolerated in Younger Patients: Risk Factors for Discontinuation from a Nationwide Database in Japan

(2021) Katsunori Toyoda et al.   Psychiatry Investigation

Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitals

(2021) Ebenezer Oloyede et al.   BMC Psychiatry

Clozapine‐induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine

(2020) Kentaro Matsui et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

The prevalence of agranulocytosis and related death in clozapine-treated patients: a comprehensive meta-analysis of observational studies

(2019) Xiao-Hong Li et al.   PSYCHOLOGICAL MEDICINE

A meta-analysis of controlled studies comparing the association between clozapine and other antipsychotic medications and the development of neutropenia

(2019) Nicholas Myles et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Meta-analysis examining the epidemiology of clozapine-associated neutropenia

(2018) N. Myles et al.   ACTA PSYCHIATRICA SCANDINAVICA

Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1–12.5 Years

(2018) Jentien M Vermeulen et al.   SCHIZOPHRENIA BULLETIN

Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis

(2016) Dan Siskind et al.   BRITISH JOURNAL OF PSYCHIATRY

Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials

(2014) Paolo Fusar-Poli et al.   SCHIZOPHRENIA BULLETIN